Abstract:Background: Cerebrospinal fluid (CSF) kappa free light chain (κFLC) measures gained increasing interest as diagnostic markers in multiple sclerosis (MS). However, the lack of studies comparing assay-dependent diagnostic cutoff values hinders their use in clinical practice. Additionally, the optimal κFLC parameter for identifying MS remains a subject of ongoing debate. Objectives: The aim of this study was to compare same-sample diagnostic accuracies of the κFLC index, κIgG index, CSF κFLC/IgG ratio, and isolated CSF κFLC (iCSF-κFLC) between two reference centers using different methods. Methods: Paired serum and CSF samples were analyzed for κFLC and albumin concentrations by Freelite ® -Optilite (Sint-Jan Bruges hospital) and N Latex ® -BNII (Ghent University hospital). Diagnostic performance to differentiate MS from controls was assessed using ROC curve analysis. Results: A total of 263 participants were included (MS, n = 80). Optimal diagnostic cutoff values for the κFLC index (Freelite ® -Optilite: 7.7; N Latex ® -BNII: 4.71), κIgG index (Freelite ® -Optilite: 14.15, N Latex ® -BNII: 12.19), and CSF κFLC/IgG ratio (Freelite ® -Optilite: 2.27; N Latex ® -BNII: 1.44) differed between the two methods. Sensitivities related to optimal cutoff values were 89.9% (Freelite ® -Optilite) versus 94.6% (N Latex ® -BNII) for the κFLC index, 91% (Freelite ® -Optilite) versus 92.2% (N Latex ® -BNII) for the κIgG index, and 81.3% (Freelite ® -Optilite) versus 91.4% (N Latex ® -BNII) for the CSF κFLC/IgG ratio. However, for iCSF-κFLC, optimal diagnostic cutoff values (0.36 mg/L) and related specificities (81.8%) were identical with a related diagnostic sensitivity of 89.9% for Freelite ® -Optilite and 90.5% for N Latex ® -BNII. The diagnostic performance of the κFLC index [area under the curve (AUC) Freelite ® -Optilite: 0.924; N Latex ® -BNII: 0.962] and κIgG index (AUC Freelite ® -Optilite: 0.929; N Latex ® -BNII: 0.961) was superior compared to CSF oligoclonal bands (AUC: 0.898, sensitivity: 83.8%, specificity: 95.9%). Conclusions: The κFLC index and the κIgG index seem to be excellent markers for identifying MS, irrespective of the method used for κFLC quantification. Based on the AUC, they appear to be the measures of choice. For all measures, optimal cutoff values differed between methods except for iCSF-κFLC. iCSF-κFLC might therefore serve as a method-independent, more cost-efficient, initial screening measure for MS. These findings are particularly relevant for clinical practice given the potential future implementation of intrathecal κFLC synthesis in MS diagnostic criteria and for future multicentre studies pooling data on κFLC measures.

A Comparison of IgG Index and Oligoclonal Band in the Cerebrospinal Fluid for Differentiating between RRMS and NMOSD

IgG Index for Multiple Sclerosis Diagnosis: Old Test Do the Trick (2064)

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis

Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder

Brain Lesion Distribution Criteria Distinguish Demyelinating Diseases in China.

Serum Aquaporin 4-Immunoglobulin G Titer and Neuromyelitis Optica Spectrum Disorder Activity and Severity: A Systematic Review and Meta-Analysis

[The combined application of oligoclonal bands in cerebrospinal fluid and IgG intrathecal synthesis indicators and biochemical markers in the diagnosis of multiple sclerosis]

Clinical Significance of Oligoclonal Bands and IgG Index for Multiple Sclerosis

Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.

Cerebrospinal Fluid Oligoclonal Bands in Chinese Patients with Multiple Sclerosis: the Prevalence and Its Association with Clinical Features

Comparison on the Clinic Features and Neuromyelitis Optica-Igg Positive Rate of Neuromyelitis Optica and Multiple Sclerosis

Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis

Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

Clinical laboratory test utilization of CSF oligoclonal bands and IgG index in a tertiary pediatric hospital

Differentiation of Neuromyelitis Optica from Multiple Sclerosis in a Cohort from the Mainland of China

A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective

Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement